Because of limited data on dengue virus in Burkina Faso, we conducted 4 consecutive age-stratified longitudinal serologic surveys, ≈6 months apart, among persons 1-55 years of age, during June 2015-March 2017, which included a 2016 outbreak. The seroconversion rate before the serosurvey enrollment was estimated by binomial regression, taking age as the duration of exposure, and assuming constant force of infection (FOI) over age and calendar time. We calculated FOI between consecutive surveys and rate ratios for potentially associated characteristics based on seroconversion using the duration of intervals. Among 2,897 persons at enrollment, 66.3% were IgG-positive, and estimated annual FOI was 5.95%. Of 1,269 enrollees participating in all ...
<div><p>Background</p><p>Estimates of dengue transmission intensity remain ambiguous. Since the majo...
Abstract Background Stratifying dengue risk within endemic countries is crucial for allocating limit...
<p>Estimates of the force of infection (λ, summed across all serotypes) obtained from models fit to ...
Because of limited data on dengue virus in Burkina Faso, we conducted 4 consecutive age-stratified l...
Because of limited data on dengue virus in Burkina Faso, we conducted 4 consecutive age-stratified l...
Dengue virus (DENV) is the most prevalent human vector-borne viral disease. The force of infection (...
<p>A) Very low transmission 10% seroprevalence at age 9, B) medium transmission 50% seroprevalence a...
The extent to which dengue virus has been circulating globally and especially in Africa is largely u...
Owing to the finding that Dengvaxia® (the only licensed dengue vaccine to date) increases the risk o...
Background Dengue is prevalent in as many as 128 countries with more than 100 million clinical episo...
Background In Africa, the magnitude of dengue virus (DENV) transmission is largely unknown. In Burki...
Background: The significant malaria burden in Africa has often eclipsed other febrile illnesses. Bur...
Introduction Dengue is an important and well documented public health problem in the Asia-Pacific an...
In recent decades, the global incidence of dengue has risen sharply, with more than 75% of infected ...
Despite being the most widely distributed mosquito-borne viral infection, estimates of dengue transm...
<div><p>Background</p><p>Estimates of dengue transmission intensity remain ambiguous. Since the majo...
Abstract Background Stratifying dengue risk within endemic countries is crucial for allocating limit...
<p>Estimates of the force of infection (λ, summed across all serotypes) obtained from models fit to ...
Because of limited data on dengue virus in Burkina Faso, we conducted 4 consecutive age-stratified l...
Because of limited data on dengue virus in Burkina Faso, we conducted 4 consecutive age-stratified l...
Dengue virus (DENV) is the most prevalent human vector-borne viral disease. The force of infection (...
<p>A) Very low transmission 10% seroprevalence at age 9, B) medium transmission 50% seroprevalence a...
The extent to which dengue virus has been circulating globally and especially in Africa is largely u...
Owing to the finding that Dengvaxia® (the only licensed dengue vaccine to date) increases the risk o...
Background Dengue is prevalent in as many as 128 countries with more than 100 million clinical episo...
Background In Africa, the magnitude of dengue virus (DENV) transmission is largely unknown. In Burki...
Background: The significant malaria burden in Africa has often eclipsed other febrile illnesses. Bur...
Introduction Dengue is an important and well documented public health problem in the Asia-Pacific an...
In recent decades, the global incidence of dengue has risen sharply, with more than 75% of infected ...
Despite being the most widely distributed mosquito-borne viral infection, estimates of dengue transm...
<div><p>Background</p><p>Estimates of dengue transmission intensity remain ambiguous. Since the majo...
Abstract Background Stratifying dengue risk within endemic countries is crucial for allocating limit...
<p>Estimates of the force of infection (λ, summed across all serotypes) obtained from models fit to ...